Sonoma Pharmaceuticals (SNOA) Current Assets (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Current Assets of $12.1 million for Q1 2026, down 4.33% year-over-year from $12.6 million in Q1 2025, and little changed quarter-over-quarter from $12.1 million in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Current Assets (2011 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Current Assets history runs 16 years deep, the most recent figure standing at $12.1 million for Q1 2026.
- In Q1 2026, Current Assets fell 4.33% year-over-year to $12.1 million; the TTM figure through Mar 2026 stood at $12.1 million (down 4.33% YoY), while the FY2026 annual figure was $12.1 million, down 4.33% from the prior year.
- Current Assets for Q1 2026 stood at $12.1 million, roughly flat from $12.1 million in the prior quarter.
- The five-year high for Current Assets was $16.4 million in Q1 2022, with the low at $11.2 million in Q4 2022.
- The 5-year median for Current Assets is $12.5 million (2025), against an average of $12.8 million.
- Peak annual rise in Current Assets reached 26.55% in 2022, while the deepest fall reached 36.54% in 2022.
- Sonoma Pharmaceuticals' Current Assets stood at $11.2 million in 2022, then climbed by 11.31% to $12.5 million in 2023, then retreated by 0.98% to $12.4 million in 2024, then fell by 1.9% to $12.1 million in 2025, then decreased by 0.37% to $12.1 million in 2026.
- Business Quant data shows SNOA's Current Assets at $12.1 million in Q1 2026, $12.1 million in Q4 2025, and $12.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 16.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.27 Mn |
| Mar 31, 2026 | 12.10 Mn |
| Dec 31, 2025 | 12.15 Mn |
| Sep 30, 2025 | 12.50 Mn |
| Jun 30, 2025 | 13.11 Mn |
| Mar 31, 2025 | 12.65 Mn |
| Dec 31, 2024 | 12.38 Mn |
| Sep 30, 2024 | 12.22 Mn |
| Jun 30, 2024 | 11.93 Mn |
| Mar 31, 2024 | 12.55 Mn |
| Dec 31, 2023 | 12.50 Mn |
| Sep 30, 2023 | 11.52 Mn |
| Jun 30, 2023 | 13.59 Mn |
| Mar 31, 2023 | 13.80 Mn |
| Dec 31, 2022 | 11.23 Mn |
| Sep 30, 2022 | 12.39 Mn |
| Jun 30, 2022 | 14.82 Mn |
| Mar 31, 2022 | 16.43 Mn |
| Dec 31, 2021 | 17.70 Mn |
| Sep 30, 2021 | 18.02 Mn |